BoC Holds Rates at 2.25% Amid Energy Volatility; US Crude Exports Hit Record 6M BPD
Key Takeaways Bank of Canada maintains the benchmark interest rate at 2.25%, though Governor Tiff Macklem warned that persistent energy […]
Breaking News
Oil Surges as US Inventories Plunge; Kevin Warsh Clears Key Hurdle for Fed Chair
Key Takeaways US crude oil inventories plummeted by 6.234 million barrels for the week ending April 24, a massive draw
Oil Surges to $116 Amid Iran Tensions; US Housing Starts Hit 2024 Highs
Key Takeaways Brent Crude oil prices surged to a session high near $116 per barrel following reports of a potential
AbbVie Beats Q1 Estimates as UAE Exits OPEC; Google Launches AI Migration Tools
Key Takeaways AbbVie (ABBV) reported Q1 revenue of $15.002 billion, surpassing analyst estimates of $14.722 billion, driven by surging sales
Corporate Earnings Surge Led by Defense and Fast Food; GE Healthcare Cuts Outlook
Key Takeaways General Dynamics (GD) delivered a massive Q1 beat, reporting revenue of $13.48 billion and Free Cash Flow of
Healthcare Giants Slash Guidance Despite Q1 Beats; UAE Exits OPEC Amid Rising Geopolitical Tensions
Key Takeaways Humana (HUM) and Biogen (BIIB) both lowered full-year earnings guidance despite beating Q1 estimates, highlighting persistent margin pressures
Geopolitical Tensions Drive Crude to $113 as Yum China Beats Q1 Estimates
Key Takeaways Brent crude oil surged 2.3% to reach $113.8 per barrel as persistent disruptions in the Middle East continue
UAE to Exit OPEC Amid Hormuz Crisis; Trump Image Slated for US Passports
Key Takeaways UAE to exit OPEC and OPEC+ effective May 1, 2026, signaling a shift toward independent production as Fujairah
Iran War Costs UK Drivers £2 Billion as Global Markets Face Energy and Regulatory Shocks
Key Takeaways UK drivers face a £2 billion surge in fuel costs due to the ongoing conflict with Iran, placing
Q1 2026 Earnings Roundup: TotalEnergies, AstraZeneca, and GSK Beat Estimates Amid Geopolitical Headwinds
Key Takeaways TotalEnergies (TTE), AstraZeneca (AZN), and GSK (GSK) all surpassed Q1 2026 analyst expectations, driven by strong operational performance